We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

125 hedge funds and large institutions have $34.8M invested in Sanofi Contingent Value Rights in 2014 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 27 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less funds holding

Funds holding: 130 → 125 (-5)

15% less capital invested

Capital invested by funds: $40.7M → $34.8M (-$5.98M)

19% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 27

31% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 16

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
125
Holders Change
-5
Holders Change %
-3.85%
% of All Funds
3.61%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
22
Reduced
27
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GCM
Gruss Capital Management
New York
+$929K
2
PWAM
Park West Asset Management
California
+$864K
3
SM
Scoggin Management
New York
+$743K
4
Brown Advisory
Brown Advisory
Maryland
+$483K
5
Citigroup
Citigroup
New York
+$372K

Top Sellers

Rank Fund Capital Flow
1
ACM
Abrams Capital Management
Massachusetts
-$3.96M
2
SI
Standard Investments
New York
-$819K
3
PI
Putnam Investments
Massachusetts
-$427K
4
AGCJ
Alden Global Capital (Jersey)
Jersey
-$425K
5
WA
Whitebox Advisors
Minnesota
-$360K
Name Holding Trade Value Shares
Change 		Change in
Stake
CTC
76
Central Trust Company
Missouri
$2K -$74 -200 -3%
Deutsche Bank
77
Deutsche Bank
Germany
$2K – – –
Bank of Montreal
78
Bank of Montreal
Ontario, Canada
$2K +$2.3K +6,193 +1,272%
M&T Bank
79
M&T Bank
New York
$1K -$260 -700 -23%
WT
80
Whittier Trust
California
$1K -$115 -310 -14%
BPBT
81
Boston Private Bank & Trust
Massachusetts
$1K -$112 -300 -7%
Royal Bank of Canada
82
Royal Bank of Canada
Ontario, Canada
$1K -$12 -31 -2%
HF
83
Hoxton Financial
West Virginia
$1K – – –
LTFS
84
Ladenburg Thalmann Financial Services
Florida
$1K – – –
NEAM
85
New England Asset Management
Connecticut
$1K – – –
RNS
86
Robert N. Shapiro
$1K – – –
TWA
87
TCI Wealth Advisors
Arizona
$1K – – –
WTC
88
WhitTier Trust Company
Nevada
$1K – – –
SAM
89
Silverback Asset Management
North Carolina
$491 -$216K -581,099 -27%
CFA
90
CT Financial Advisors
Pennsylvania
$408 +$224 +602 New
AIG
91
American International Group
New York
$407 – – –
ACS
92
Archford Capital Strategies
Illinois
$211 +$253 +680 New
WEC
93
Winslow Evans & Crocker
Massachusetts
$163 – – –
ECM
94
Estabrook Capital Management
New York
$4 – – –
MPWT
95
MassMutual Private Wealth & Trust
Connecticut
$4 – – –
Manulife (Manufacturers Life Insurance)
96
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3 – – –
ACM
97
Abrams Capital Management
Massachusetts
– -$3.96M -11,658,873 Closed
SI
98
Standard Investments
New York
– -$819K -2,409,579 Closed
PI
99
Putnam Investments
Massachusetts
– -$427K -1,255,462 Closed
AGCJ
100
Alden Global Capital (Jersey)
Jersey
– -$425K -1,251,300 Closed
1 2 3
4
5

GCVRZ Hedge Fund Activity: Q1 2014 in Review

125 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2014, worth a combined $34.8M — down 15% from $40.7M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of GCVRZ and 11 opened new positions — a net loss of 5 holders — while 27 trimmed existing stakes and 22 added.

The largest buyer was Gruss Capital Management, adding an estimated $929K. The largest seller was Abrams Capital Management, exiting entirely with an estimated $3.96M sold.

  • 125 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2014, down from 130 in Q4 2013.
  • Funds reported $34.8M of Sanofi Contingent Value Rights stock for Q1 2014, down 15% quarter-over-quarter.
  • 11 funds opened new Sanofi Contingent Value Rights positions in Q1 2014 and 16 closed out, a net change of -5 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q1 2014 was Gruss Capital Management, an estimated $929K added.
  • The largest Sanofi Contingent Value Rights seller in Q1 2014 was Abrams Capital Management, an estimated $3.96M sold.

Based on aggregated 13F filings for Q1 2014.